scispace - formally typeset
M

Michael N. Sack

Researcher at National Institutes of Health

Publications -  145
Citations -  16742

Michael N. Sack is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Mitochondrion & SIRT3. The author has an hindex of 55, co-authored 135 publications receiving 15105 citations. Previous affiliations of Michael N. Sack include Georgetown University Medical Center & University of Cape Town.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS)

TL;DR: ROS generated by mitochondrial respiration are needed for optimal proinflammatory cytokine production in healthy cells, and are elevated in cells from patients with an autoinflammatory disorder.
Journal ArticleDOI

Fatty Acid Oxidation Enzyme Gene Expression Is Downregulated in the Failing Heart

TL;DR: Findings identify a gene regulatory pathway involved in the control of cardiac energy production during the development of HF, which is thought to maintain aerobic energetic balance.
Journal ArticleDOI

Myocardial Protection by Insulin at Reperfusion Requires Early Administration and Is Mediated via Akt and p70s6 Kinase Cell-Survival Signaling

TL;DR: Insulin administration at reperfusion reduces myocardial infarction, is dependent on early administration during reperfusions, and is mediated via Akt and p70s6 kinase dependent signaling pathway.
Journal ArticleDOI

Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women

TL;DR: An antioxidant effect of physiological levels of 17 beta-oestradiol, which may contribute to an anti-atherogenic action is shown in 18 postmenopausal women.